Home > Press > Pioneering medical nanotechnology offers new cancer breakthrough hope
This is a transmission electron micrograph of the magnetic nanoparticles that will be used in this study.
Credit: Credit: Professor Chris Binns, Department of Physics and Astronomy, University of Leicester |
Abstract:
University of Leicester team examine potential of new technology to pave way for development of a combined diagnosis/therapeutic strategy
A multi-disciplinary team of scientists from the University of Leicester could be potentially paving the way for the development of a powerful new strategy for both the early diagnosis and treatment of prostate cancer.
The research is to use cutting edge nanotechnology to identify a pioneering treatment which could also be applied to other aggressive cancers.
The University of Leicester researchers say that microscopic (5-100 nm) magnetic nanoparticles could be applied in the sensitive diagnosis and effective treatment of prostate cancer. This follows breakthrough nanotechnology research at the University.
Dr Wu Su, of the Department of Chemistry, has been awarded a grant worth £321 K. This is one of only ten Postdoctoral Research Fellowships in the Life Sciences Interface area given this year by the Engineering and Physical Sciences Research Council (EPSRC). This is the first EPSRC postdoctoral research fellowship awarded to the University of Leicester.
The highly prestigious award will allow a multi-disciplinary research team to design high-performance magnetic nanoparticles. The team consists of researchers from the University of Leicester departments of Chemistry, Physics, Cancer Studies and Molecular Medicine and Cardiovascular Sciences.
High-performance magnetic nanoparticles act as probes that show up (using Magnetic Resonance Imaging) and kill (by hyperthermia) tumour cells at a much earlier stage than conventional methods.
The pioneering technology, developed at the University of Leicester, is focused on the development of a new type of magnetic nanoparticle in which the magnetic performance is increase by a factor of ten. Targeting these magnetic nanoparticles to unique cell surface receptors present on the prostate tumour cell surface will enable efficient and specific delivery to prostate cancer cells. The approach is general and it is envisaged that these systems could be applied to other types of aggressive cancers [liver, breast, colon] in which early diagnosis and treatment is essential for recovery.
Dr Su said this technology requires a multidisciplinary approach: "Prostate cancer cure rates are predicated on early diagnosis and treatment. The technology that we are developing offers the potential of both the identification and treatment of prostate cancer in a highly selective manner."
Successful implementation of this technology would provide significant welfare benefits for patients [reducing the need for surgical removal of the prostate] and significant cost benefits for the UK health-care system.
Notes to Editors
Dr Su is currently a postdoctoral Research Associate in Dr. Burley's lab within the department of Chemistry and has in the past worked in prestigious institutions such as the Max Plank Institute, Germany and the Institute of Biological Chemistry, Shanghai. Dr Su will help co-ordinate this Leicester-based research team involving Physicists, Chemists, Medics and Magnetic Resonance Imaging experts.
About the EPSRC
The Engineering and Physical Sciences Research Council (EPSRC) is the UK's main agency for funding research in engineering and the physical sciences. The EPSRC invests more than £740 million a year in research and postgraduate training, to help the nation handle the next generation of technological change.
www.epsrc.ac.uk
####
For more information, please click here
Contacts:
Dr Glenn Burley
Department of Chemistry
www.burleylabs.co.uk
Ph. 44 0116 252 2140
Dr Wu Su
Department of Chemistry
University of Leicester
Research Team:
Prof. Chris Binns
Department of Physics
Dr Andrew Ellis
Department of Chemistry
Prof. J. Kilian Mellon
Department of Cancer Studies and Molecular Medicine
Dr Mark Horsfield
Department of Cardiovascular Sciences
Copyright © University of Leicester
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Imaging
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023
Observation of left and right at nanoscale with optical force October 6th, 2023
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Discoveries
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||